Vaccination strategies incorporating the immunodominant HLA-A2-restricted HER2/(HER2) is amplified in several

Vaccination strategies incorporating the immunodominant HLA-A2-restricted HER2/(HER2) is amplified in several great malignancies including breasts (BC) ovarian gastric and pancreatic malignancies (1). in HER2pos tumors (7). The tumoricidal activity of antigen-specific Compact disc8+ cytotoxic Tlymphocytes (CTL) can be widely appreciated; certainly Compact disc8+ T cells spotting the HLA-A2-limited peptide 369-377 (HER2369-377; KIFGSLAFL) have already been… Continue reading Vaccination strategies incorporating the immunodominant HLA-A2-restricted HER2/(HER2) is amplified in several